GOULD CAPITAL, LLC Corcept Therapeutics Incorporated Transaction History

GOULD CAPITAL, LLC portfolio value:

$13,000
portfolio value

GOULD CAPITAL, LLC quarter portfolio value change:

+7.82%
quarter

Corcept Therapeutics Incorporated 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 1K $25.64 500
Q2 2022 share 0.00% 0 shares 1K $23.78 500
Q1 2022 share 0.00% 0 shares 1K $22.52 500
Q4 2021 share Increase 0.00% 500 shares 10K $19.48 500